58 results
424B4
LGVN
Longeveron Inc - Ordinary Shares
17 Apr 24
Prospectus supplement with pricing info
5:07pm
infringing the intellectual property rights of others;
the need to hire additional personnel and our ability to attract and retain such personnel
424B4
LGVN
Longeveron Inc - Ordinary Shares
10 Apr 24
Prospectus supplement with pricing info
7:48am
where available and our ability to avoid infringing the intellectual property rights of others;
the need to hire additional personnel and our ability
8-K
EX-99.1
5hd t765o
22 Dec 23
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:44am
424B5
jyryz7z42lrwyc
22 Dec 23
Prospectus supplement for primary offering
8:36am
424B3
zi9fgff22g2518s
6 Dec 23
Prospectus supplement
4:05pm
8-K
EX-99.1
7qgeapuk pl6t
13 Oct 23
Longeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:00am
424B5
3qhtk2 qu5e
13 Oct 23
Prospectus supplement for primary offering
6:07am
8-K
EX-99.2
n8m88ow1mn v9y9
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
8-K
EX-99.1
nxwy7
5 Oct 23
Longeveron Announces Positive Top-Line Results for Lomecel-BTM in its CLEAR MIND Phase 2a Clinical Trial in the Treatment of Mild Alzheimer’s Disease
7:36am
8-K
EX-99.1
awnu84y5 u5c6npcw6e
16 Aug 23
Longeveron Rights Offering Declared Effective and Calendar Finalized
5:27pm
424B3
74kvr 0z7g
14 Aug 23
Prospectus supplement
4:45pm